| Name | Title | Contact Details |
|---|---|---|
Jeremiah Hanes |
VP, Reagents R&D | Profile |
Jasmine Pritchard |
Vice President, Product Marketing | Profile |
Alex Nemiroski |
Director of Consumables R&D | Profile |
Natalie Welch |
Vice President Human Resources and Organization Development | Profile |
Alvin Hom |
Head of Global Talent Acquisition | Profile |
Our patented and award-winning Highlight® technology makes it easy to use disinfectants correctly.
Leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer.
ElevateBio is accelerating the future of biotechnology. We have a launched a revolutionary new model that integrates innovators, infrastructure and capital to effectively develop cell, gene and related therapies for patients with severe and life-threatening disorders.
jCyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. The Company`s allogeneic product candidate, jCell, is delivered by simple intravitreal injection without the need for surgery or immune suppression. jCyte has completed a phase 1/2a, phase 1/2a extension and phase 2b clinical trials testing jCell in patients with Retinitis Pigmentosa.
HotSpot Therapeutics is discovering new allosteric therapies with the ability to treat disease in new ways.